Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Reifenberger

Showing results (131-140 of 142) with videos related to

Pageof 15
Sort By:
Oncogene|November 10, 2015
Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasivenessM Schulze, O Fedorchenko, T G Zink, et al.
Oncogene|November 8, 2011
RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survivalV Goidts, J Bageritz, L Puccio, et al.
Oncogene|August 16, 2006
Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomasR G Weber, A Hoischen, M Ehrler, et al.
Leukemia|November 9, 2007
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cellM Montesinos-Rongen, A Brunn, S Bentink, et al.
Oncogene|October 31, 2012
miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cellsN Kliese, P Gobrecht, D Pachow, et al.
Oncogene|December 14, 2011
Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitroL M Dittmann, A Danner, J Gronych, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 1998
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSLJ M Cobbers, M Wolter, J Reifenberger, et al.
Nature Communications|July 30, 2016
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistanceC Depner, H Zum Buttel, N Böğürcü, et al.
Neuropathology and Applied Neurobiology|July 23, 2020
Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnosticsJ K Petersen, H B Boldt, M D Sørensen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 10, 2021
Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analysesA C Nickel, D Picard, N Qin, et al.
Pageof 15

Showing results (131-140 of 142) with videos related to

Sort By:
Pageof 15
Oncogene|November 10, 2015
Chronophin is a glial tumor modifier involved in the regulation of glioblastoma growth and invasivenessM Schulze, O Fedorchenko, T G Zink, et al.
Oncogene|November 8, 2011
RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survivalV Goidts, J Bageritz, L Puccio, et al.
Oncogene|August 16, 2006
Frequent loss of chromosome 9, homozygous CDKN2A/p14(ARF)/CDKN2B deletion and low TSC1 mRNA expression in pleomorphic xanthoastrocytomasR G Weber, A Hoischen, M Ehrler, et al.
Leukemia|November 9, 2007
Gene expression profiling suggests primary central nervous system lymphomas to be derived from a late germinal center B cellM Montesinos-Rongen, A Brunn, S Bentink, et al.
Oncogene|October 31, 2012
miRNA-145 is downregulated in atypical and anaplastic meningiomas and negatively regulates motility and proliferation of meningioma cellsN Kliese, P Gobrecht, D Pachow, et al.
Oncogene|December 14, 2011
Downregulation of PRDX1 by promoter hypermethylation is frequent in 1p/19q-deleted oligodendroglial tumours and increases radio- and chemosensitivity of Hs683 glioma cells in vitroL M Dittmann, A Danner, J Gronych, et al.
Brain Pathology (Zurich, Switzerland)|April 18, 1998
Frequent inactivation of CDKN2A and rare mutation of TP53 in PCNSLJ M Cobbers, M Wolter, J Reifenberger, et al.
Nature Communications|July 30, 2016
EphrinB2 repression through ZEB2 mediates tumour invasion and anti-angiogenic resistanceC Depner, H Zum Buttel, N Böğürcü, et al.
Neuropathology and Applied Neurobiology|July 23, 2020
Targeted next-generation sequencing of adult gliomas for retrospective prognostic evaluation and up-front diagnosticsJ K Petersen, H B Boldt, M D Sørensen, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 10, 2021
Longitudinal stability of molecular alterations and drug response profiles in tumor spheroid cell lines enables reproducible analysesA C Nickel, D Picard, N Qin, et al.
Pageof 15